This Week’s Biopharma News: Wave of Antibody Approvals
FDA expands Tzield, EU clears Dupixent, and Health Canada approves denosumab antibody biosimilars
False
FDA expands Tzield, EU clears Dupixent, and Health Canada approves denosumab antibody biosimilars
This content is an AI-generated, fully rewritten summary based on a published scholarly article. It does not reproduce the original text and is not a substitute for the original publication. Readers are encouraged to consult the source for full context, data, and methodology.
False
False
October 7, 2026
2 min read
Mayo Clinic and Thermo Fisher launch a large-scale multi-omics resource designed to reveal disease before symptoms appear
October 5, 2026
4 min read
Regeneron's L. Andres Sirulnik explains why modernizing clinical trials is as important as developing new medicines
September 30, 2026
2 min read
Fayuvi is authorized for pediatric patients with preserved neurodevelopmental function following a study comparing treated children with a natural history cohort
September 28, 2026
3 min read
Phase I study will test whether a targeted lentiviral vector can generate BCMA-directed CAR T cells inside patients with multiple myeloma
False
Affiliations:
Specialties:
Areas of Expertise: